Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer

The Journal of Gene Medicine
Sabine BoeckleManfred Ogris

Abstract

Nonviral vectors based on polyethylenimine (PEI) usually contain an excess of PEI that is not complexed to DNA. Since unbound PEI contributes to cellular and systemic toxicity, purification of polyplexes from unbound PEI is desirable. Size exclusion chromatography (SEC) was used to purify PEI polyplexes of free PEI. Transfection properties of purified polyplexes and the effect of free PEI on gene delivery were studied in vitro and in vivo after systemic application into mice. SEC did not change the size and zeta-potential of polyplexes. Independent of the amount of PEI used for complex formation, purified PEI polyplexes had the same final PEI nitrogen/DNA phosphate ratio of 2.5. Notably, purified PEI polyplexes demonstrated low cellular and systemic toxicity. High transfection efficiency was achieved with purified polyplexes at high DNA concentrations (8-15 microg/ml). At low DNA concentrations (2-4 microg/ml) gene transfer with purified particles was less efficient than with polyplexes containing free PEI both in vitro and in vivo. Mechanistic studies showed that free PEI partly blocked cellular association of DNA complexes but was essential for the following intracellular gene delivery. Adding free PEI to cells treated with p...Continue Reading

References

Mar 1, 1975·Analytical Biochemistry·S L Snyder, P Z Sobocinski
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·O BoussifJ P Behr
Aug 1, 1997·Nucleic Acids Research·D D DunlapL Monaco
May 16, 2000·The Journal of Gene Medicine·S M ZouJ P Behr
Apr 25, 2001·The Journal of Gene Medicine·A KichlerO Danos
Aug 22, 2001·Biochimica Et Biophysica Acta·A Rémy-KristensenY Mély
Nov 24, 2001·Advanced Drug Delivery Reviews·G ZuberJ P Behr
Feb 6, 2002·The Journal of Gene Medicine·Patrice CholletJean-Luc Coll
Feb 25, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kensuke MorimotoMitsuru Hashida
Aug 29, 2003·The Journal of Biological Chemistry·N D SonawaneA S Verkman

❮ Previous
Next ❯

Citations

Mar 28, 2007·Pharmaceutical Research·Verena Russ, Ernst Wagner
May 20, 2011·Pharmaceutical Research·Senta UzgünCarsten Rudolph
Apr 1, 2005·Drug Discovery Today. Technologies·Nobuhiro NishiyamaKazunori Kataoka
Mar 21, 2012·Accounts of Chemical Research·Juliane Nguyen, Francis C Szoka
Aug 3, 2010·Biomacromolecules·Daniel HönigJoachim O Rädler
Dec 18, 2012·Biomacromolecules·Hua WeiSuzie H Pun
Feb 18, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Kory M BlockerMillicent O Sullivan
Dec 7, 2011·Molecular Pharmaceutics·Mahmoud SolimanCameron Alexander
Jun 1, 2012·ACS Nano·Christian DohmenErnst Wagner
Jan 15, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sharon Y WongDavid Putnam
May 27, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lee A DaviesDeborah R Gill
Aug 27, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Arkadi ZintchenkoManfred Ogris
Oct 4, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Rikke V BenjaminsenThomas L Andresen
Oct 20, 2007·Nature Protocols·Olga MykhaylykChristian Plank
Jul 8, 2009·Diabetes Technology & Therapeutics·Han Chang Kang, You Han Bae
Oct 30, 2009·Human Gene Therapy·Alenka SchwerdtManfred Ogris
May 26, 2005·Nucleic Acids Research·Martin L ReadLeonard W Seymour
Feb 3, 2005·The European Physical Journal. E, Soft Matter·J DeRoucheyJ O Rädler
Mar 30, 2012·International Journal of Nanomedicine·Mohamad AlamehAbderrazzak Merzouki
Jan 18, 2013·Therapeutic Delivery·Florian SchlenkDagmar Fischer
Sep 16, 2014·Journal of Pharmaceutical Innovation·Yi Wen, Wilson S Meng
Jul 19, 2013·BioMed Research International·Jing XieRobert J Lee
Jul 23, 2013·Advanced Drug Delivery Reviews·Michael D BuschmannVincent Darras

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.